Effect of indomethacin on binding of bilirubin to albumin.
Department of Paediatrics, Queen Mary Hospital, University of Hong Kong.
The effect of indomethacin on the binding of bilirubin to protein was studied in vitro by the horseradish peroxidase oxidation method. Plasma indomethacin concentrations ranging from 1500 micrograms/l to 4500 micrograms/l, which were much higher than the therapeutic concentrations achieved in vivo, were used for the studies. The bilirubin-protein titration curves obtained indicate that indomethacin, although protein bound, does not affect the binding of bilirubin to protein. Our study confirms that it is safe to use conventional doses of indomethacin in jaundiced preterm infants.
This article has been cited by other articles:
-
Calhoun, D. A, Murthy, S N., Bryant, B. G, Luedtke, S. A, Bhatt-Mehta, V.
(2006). Recent Advances in Neonatal Pharmacotherapy. The Annals of Pharmacotherapy
40: 710-719
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



